Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 383.79 Million USD | -20.48% |
| 2022 | 482.61 Million USD | -1.39% |
| 2021 | 489.43 Million USD | 19.1% |
| 2020 | 410.95 Million USD | 78.94% |
| 2019 | 229.66 Million USD | 311.39% |
| 2018 | -108.64 Million USD | -193.13% |
| 2017 | 116.65 Million USD | 119.29% |
| 2016 | 53.19 Million USD | -68.09% |
| 2015 | 166.7 Million USD | 11.15% |
| 2014 | 149.98 Million USD | -11.49% |
| 2013 | 169.45 Million USD | -35.84% |
| 2012 | 264.1 Million USD | -10.52% |
| 2011 | 295.15 Million USD | 3.92% |
| 2010 | 284 Million USD | 22.95% |
| 2009 | 230.98 Million USD | 26.26% |
| 2008 | 182.94 Million USD | 35.32% |
| 2007 | 135.19 Million USD | -7.47% |
| 2006 | 146.11 Million USD | 26.72% |
| 2005 | 115.29 Million USD | 5.93% |
| 2004 | 108.84 Million USD | -25.33% |
| 2003 | 145.76 Million USD | 6.11% |
| 2002 | 137.37 Million USD | 22.63% |
| 2001 | 112.02 Million USD | 67.79% |
| 2000 | 66.76 Million USD | 37.38% |
| 1999 | 48.6 Million USD | 56.77% |
| 1998 | 31 Million USD | 16.54% |
| 1997 | 26.6 Million USD | -36.21% |
| 1996 | 41.7 Million USD | 5.04% |
| 1995 | 39.7 Million USD | 8.17% |
| 1994 | 36.7 Million USD | 252.88% |
| 1993 | 10.4 Million USD | -28.28% |
| 1992 | 14.5 Million USD | -34.39% |
| 1991 | 22.1 Million USD | -9.43% |
| 1990 | 24.4 Million USD | 15.64% |
| 1989 | 21.1 Million USD | 6.57% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 52 Million USD | -46.82% |
| 2024 Q3 | 58.36 Million USD | -35.72% |
| 2024 Q2 | 100.29 Million USD | 92.85% |
| 2023 Q3 | 90.94 Million USD | 1.49% |
| 2023 Q2 | 89.61 Million USD | -20.23% |
| 2023 FY | 383.79 Million USD | -20.48% |
| 2023 Q4 | 97.79 Million USD | 7.52% |
| 2023 Q1 | 112.34 Million USD | -5.33% |
| 2022 Q2 | 120.21 Million USD | -16.18% |
| 2022 Q1 | 143.42 Million USD | 34.06% |
| 2022 FY | 482.61 Million USD | -1.39% |
| 2022 Q4 | 118.67 Million USD | 27.88% |
| 2022 Q3 | 92.79 Million USD | -22.81% |
| 2021 FY | 489.43 Million USD | 19.1% |
| 2021 Q1 | 100.86 Million USD | -42.44% |
| 2021 Q2 | 124.78 Million USD | 23.72% |
| 2021 Q3 | 156.8 Million USD | 25.66% |
| 2021 Q4 | 106.98 Million USD | -31.77% |
| 2020 Q4 | 175.24 Million USD | 59.89% |
| 2020 Q3 | 109.6 Million USD | 111.82% |
| 2020 Q2 | 51.74 Million USD | -30.43% |
| 2020 Q1 | 74.37 Million USD | 25.62% |
| 2020 FY | 410.95 Million USD | 78.94% |
| 2019 Q2 | 56.39 Million USD | -0.38% |
| 2019 Q4 | 59.2 Million USD | 3.04% |
| 2019 Q1 | 56.6 Million USD | 124.36% |
| 2019 Q3 | 57.46 Million USD | 1.9% |
| 2019 FY | 229.66 Million USD | 311.39% |
| 2018 Q3 | 36.27 Million USD | -17.17% |
| 2018 Q4 | -232.35 Million USD | -740.53% |
| 2018 FY | -108.64 Million USD | -193.13% |
| 2018 Q1 | 43.64 Million USD | -7.26% |
| 2018 Q2 | 43.79 Million USD | 0.33% |
| 2017 Q3 | 46.37 Million USD | 2072.74% |
| 2017 Q4 | 47.06 Million USD | 1.47% |
| 2017 Q1 | 25.55 Million USD | 210.4% |
| 2017 FY | 116.65 Million USD | 119.29% |
| 2017 Q2 | -2.35 Million USD | -109.2% |
| 2016 Q4 | -23.15 Million USD | -182.41% |
| 2016 FY | 53.19 Million USD | -68.09% |
| 2016 Q2 | 22.52 Million USD | -12.45% |
| 2016 Q1 | 25.72 Million USD | -56.75% |
| 2016 Q3 | 28.09 Million USD | 24.72% |
| 2015 FY | 166.7 Million USD | 11.15% |
| 2015 Q2 | 40.2 Million USD | 17.05% |
| 2015 Q3 | 32.67 Million USD | -18.74% |
| 2015 Q4 | 59.48 Million USD | 82.07% |
| 2015 Q1 | 34.34 Million USD | -32.1% |
| 2014 FY | 149.98 Million USD | -11.49% |
| 2014 Q4 | 50.58 Million USD | 52.18% |
| 2014 Q2 | 45.68 Million USD | 123.18% |
| 2014 Q1 | 20.47 Million USD | -60.87% |
| 2014 Q3 | 33.24 Million USD | -27.24% |
| 2013 Q1 | 33.55 Million USD | -53.53% |
| 2013 Q2 | 51.54 Million USD | 53.62% |
| 2013 Q3 | 29.05 Million USD | -43.63% |
| 2013 FY | 169.45 Million USD | -35.84% |
| 2013 Q4 | 52.31 Million USD | 80.04% |
| 2012 FY | 264.1 Million USD | -10.52% |
| 2012 Q2 | 73.3 Million USD | 34.84% |
| 2012 Q1 | 54.36 Million USD | -36.73% |
| 2012 Q4 | 72.2 Million USD | 12.41% |
| 2012 Q3 | 64.23 Million USD | -12.38% |
| 2011 FY | 295.15 Million USD | 3.92% |
| 2011 Q3 | 73.92 Million USD | 8.41% |
| 2011 Q2 | 68.18 Million USD | 1.59% |
| 2011 Q4 | 85.93 Million USD | 16.24% |
| 2011 Q1 | 67.11 Million USD | -13.71% |
| 2010 FY | 284 Million USD | 22.95% |
| 2010 Q2 | 68.17 Million USD | 7.79% |
| 2010 Q1 | 63.24 Million USD | 12.35% |
| 2010 Q3 | 74.8 Million USD | 9.72% |
| 2010 Q4 | 77.78 Million USD | 3.99% |
| 2009 FY | 230.98 Million USD | 26.26% |
| 2009 Q4 | 56.29 Million USD | -16.44% |
| 2009 Q3 | 67.37 Million USD | 20.55% |
| 2009 Q2 | 55.88 Million USD | 8.65% |
| 2009 Q1 | 51.43 Million USD | 130.64% |
| 2008 Q3 | 51.19 Million USD | -14.26% |
| 2008 FY | 182.94 Million USD | 35.32% |
| 2008 Q4 | 22.3 Million USD | -56.44% |
| 2008 Q1 | 49.73 Million USD | 115.02% |
| 2008 Q2 | 59.7 Million USD | 20.04% |
| 2007 Q4 | 23.13 Million USD | -38.36% |
| 2007 Q2 | 35.68 Million USD | -8.14% |
| 2007 Q1 | 38.85 Million USD | 51.36% |
| 2007 FY | 135.19 Million USD | -7.47% |
| 2007 Q3 | 37.52 Million USD | 5.15% |
| 2006 Q4 | 25.66 Million USD | -14.01% |
| 2006 Q3 | 29.85 Million USD | -30.94% |
| 2006 Q2 | 43.22 Million USD | -8.74% |
| 2006 Q1 | 47.36 Million USD | 116.39% |
| 2006 FY | 146.11 Million USD | 26.72% |
| 2005 FY | 115.29 Million USD | 5.93% |
| 2005 Q4 | 21.89 Million USD | -13.82% |
| 2005 Q3 | 25.4 Million USD | -9.03% |
| 2005 Q2 | 27.92 Million USD | -30.34% |
| 2005 Q1 | 40.08 Million USD | 56.43% |
| 2004 Q2 | 33.91 Million USD | -6.21% |
| 2004 Q4 | 25.62 Million USD | 107.84% |
| 2004 Q3 | 12.32 Million USD | -63.65% |
| 2004 Q1 | 36.16 Million USD | 7.45% |
| 2004 FY | 108.84 Million USD | -25.33% |
| 2003 Q4 | 33.65 Million USD | 1.09% |
| 2003 Q3 | 33.29 Million USD | -3.91% |
| 2003 Q2 | 34.64 Million USD | -21.55% |
| 2003 Q1 | 44.16 Million USD | 32.21% |
| 2003 FY | 145.76 Million USD | 6.11% |
| 2002 FY | 137.37 Million USD | 22.63% |
| 2002 Q4 | 33.4 Million USD | -6.22% |
| 2002 Q3 | 35.62 Million USD | 8.01% |
| 2002 Q2 | 32.98 Million USD | -6.94% |
| 2002 Q1 | 35.44 Million USD | 2.89% |
| 2001 FY | 112.02 Million USD | 67.79% |
| 2001 Q4 | 34.44 Million USD | 67.55% |
| 2001 Q1 | 30.32 Million USD | 103.44% |
| 2001 Q3 | 20.55 Million USD | -23.0% |
| 2001 Q2 | 26.7 Million USD | -11.95% |
| 2000 Q1 | 18.37 Million USD | 49.41% |
| 2000 Q4 | 14.9 Million USD | -2.17% |
| 2000 Q3 | 15.23 Million USD | -16.51% |
| 2000 Q2 | 18.24 Million USD | -0.7% |
| 2000 FY | 66.76 Million USD | 37.38% |
| 1999 Q1 | 16.7 Million USD | 89.77% |
| 1999 Q3 | 7 Million USD | -44.0% |
| 1999 FY | 48.6 Million USD | 56.77% |
| 1999 Q4 | 12.3 Million USD | 75.71% |
| 1999 Q2 | 12.5 Million USD | -25.15% |
| 1998 Q2 | 6.8 Million USD | -48.09% |
| 1998 FY | 31 Million USD | 16.54% |
| 1998 Q4 | 8.8 Million USD | 266.67% |
| 1998 Q1 | 13.1 Million USD | 156.86% |
| 1998 Q3 | 2.4 Million USD | -64.71% |
| 1997 Q1 | 10.7 Million USD | 18.89% |
| 1997 FY | 26.6 Million USD | -36.21% |
| 1997 Q4 | 5.1 Million USD | 30.77% |
| 1997 Q3 | 3.9 Million USD | -45.07% |
| 1997 Q2 | 7.1 Million USD | -33.64% |
| 1996 Q2 | 10 Million USD | -29.08% |
| 1996 Q1 | 14.1 Million USD | 45.36% |
| 1996 FY | 41.7 Million USD | 5.04% |
| 1996 Q4 | 9 Million USD | 1.12% |
| 1996 Q3 | 8.9 Million USD | -11.0% |
| 1995 Q3 | 8.1 Million USD | -10.99% |
| 1995 Q2 | 9.1 Million USD | -28.35% |
| 1995 FY | 39.7 Million USD | 8.17% |
| 1995 Q1 | 12.7 Million USD | 39.56% |
| 1995 Q4 | 9.7 Million USD | 19.75% |
| 1994 FY | 36.7 Million USD | 252.88% |
| 1994 Q3 | 7.3 Million USD | -18.89% |
| 1994 Q2 | 9 Million USD | -20.35% |
| 1994 Q1 | 11.3 Million USD | 1312.5% |
| 1994 Q4 | 9.1 Million USD | 24.66% |
| 1993 FY | 10.4 Million USD | -28.28% |
| 1993 Q1 | 5 Million USD | 8.7% |
| 1993 Q3 | 1.8 Million USD | -33.33% |
| 1993 Q4 | 800 Thousand USD | -55.56% |
| 1993 Q2 | 2.7 Million USD | -46.0% |
| 1992 FY | 14.5 Million USD | -34.39% |
| 1992 Q4 | 4.6 Million USD | 43.75% |
| 1992 Q3 | 3.2 Million USD | 203.23% |
| 1992 Q2 | -3.1 Million USD | -131.31% |
| 1992 Q1 | 9.9 Million USD | 167.57% |
| 1991 FY | 22.1 Million USD | -9.43% |
| 1991 Q3 | 5.2 Million USD | 6.12% |
| 1991 Q1 | 8.3 Million USD | 2.47% |
| 1991 Q2 | 4.9 Million USD | -40.96% |
| 1991 Q4 | 3.7 Million USD | -28.85% |
| 1990 Q3 | 4.2 Million USD | -16.0% |
| 1990 FY | 24.4 Million USD | 15.64% |
| 1990 Q1 | 7.1 Million USD | 54.35% |
| 1990 Q4 | 8.1 Million USD | 92.86% |
| 1990 Q2 | 5 Million USD | -29.58% |
| 1989 Q1 | 56.3 Million USD | 144.75% |
| 1989 Q2 | 5.9 Million USD | -89.52% |
| 1989 Q3 | 3.7 Million USD | -37.29% |
| 1989 Q4 | 4.6 Million USD | 24.32% |
| 1989 FY | 21.1 Million USD | 6.57% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 94.075% |
| Allurion Technologies Inc. | -78.07 Million USD | 591.555% |
| Artivion, Inc. | 5.74 Million USD | -6584.013% |
| Avanos Medical, Inc. | 4.2 Million USD | -9038.0% |
| Butterfly Network, Inc. | -145.61 Million USD | 363.578% |
| Butterfly Network, Inc. | -145.61 Million USD | 363.578% |
| Boston Scientific Corporation | 2.34 Billion USD | 83.619% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 2627.967% |
| CONMED Corporation | 130.78 Million USD | -193.453% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 74.982% |
| Paragon 28, Inc. | -37.3 Million USD | 1128.695% |
| Glaukos Corporation | -128.7 Million USD | 398.21% |
| Globus Medical, Inc. | 133.14 Million USD | -188.261% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 1053.033% |
| Integer Holdings Corporation | 167.33 Million USD | -129.365% |
| Medtronic plc | 5.14 Billion USD | 92.539% |
| Nevro Corp. | -99.3 Million USD | 486.47% |
| Owlet, Inc. | -28.63 Million USD | 1440.444% |
| Penumbra, Inc. | 73.55 Million USD | -421.809% |
| Vicarious Surgical Inc. | -80.66 Million USD | 575.784% |
| Smith & Nephew plc | 425 Million USD | 9.695% |
| Sonendo, Inc. | -57.74 Million USD | 764.662% |
| STERIS plc | 836.11 Million USD | 54.098% |
| Stryker Corporation | 3.88 Billion USD | 90.129% |
| Vapotherm, Inc. | -39.08 Million USD | 1082.078% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 69.962% |